Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Martin III, T. G.    Shuman, M. A.    Related Articles in PubMed    PubMed Citation    PubMed

BRIEF COMMUNICATION

Thrombopoietin Levels in Patients with Cirrhosis before and after Orthotopic Liver Transplantation

Thomas G. Martin III, MD; Kenneth A. Somberg, MD; Y. Gloria Meng, PhD; Robert L. Cohen, MD; Christian A. Heid; Frederic J. de Sauvage, PhD; and Marc A. Shuman, MD

15 August 1997 | Volume 127 Issue 4 | Pages 285-288

Background: Thrombocytopenia is a common manifestation of cirrhosis.

Objectives: To determine plasma thrombopoietin levels in cirrhotic patients with thrombocytopenia, monitor those levels before and after orthotopic liver transplantation, and compare thrombopoietin messenger RNA (mRNA) levels in liver samples from cirrhotic patients and controls.

Design: A cross-sectional study of patients with cirrhosis, including a small subset of patients who had orthotopic liver transplantation.

Setting: University-affiliated hospital.

Patients: 44 patients with cirrhosis, including 17 patients who had orthotopic liver transplantation.

Intervention: Orthotopic liver transplantation.

Measurements: Plasma thrombopoietin levels in all patients, platelet counts in all patients, and thrombopoietin mRNA levels in liver samples from nine patients with cirrhosis and eight controls.

Results: Thrombopoietin levels were undetectable in 39 of 44 patients with cirrhosis. In 16 of 17 patients, the levels became detectable after liver transplantation. Thrombopoietin mRNA levels were decreased in liver samples from patients with cirrhosis compared with controls (P = 0.0103).

Conclusions: The low thrombopoietin levels in cirrhotic patients with thrombocytopenia and the increased levels after orthotopic liver transplantation suggest that impaired production of thrombopoietin may contribute to thrombocytopenia associated with cirrhosis.

Author and Article Information

From the University of California, San Francisco, California, and Genentech. Inc., South San Francisco. California.
Acknowledgment: The authors thank Robert S. Warren, MD, Assistant Professor in Residence, Department of Surgery, University of California, San Francisco, for providing the normal liver tissue samples.
Grant Support: In part by grant HL54476 from the National Institutes of Health and by Genentech, Inc.
Requests for Reprints: Thomas G. Martin III, MD, Division of Hematology, University of California, San Francisco, Medical Center, Box 1270, Parnassus Avenue, San Francisco, CA 94143.
Current Author Addresses: Dr. Martin: Division of Hematology, University of California, San Francisco, Medical Center, Box 1270, Parnassus Avenue, San Francisco, CA 94143.

This article has been cited by other articles:

				A. Zahn, N. Jennings, W. H. Ouwehand, and J.-P. Allain Hepatitis C virus interacts with human platelet glycoprotein VI. J. Gen. Virol., August 1, 2006; 87(Pt 8): 2243 - 2251. [Abstract] [Full Text] [PDF]

				R. G. Romanelli, I. Petrai, G. Robino, E. Efsen, E. Novo, A. Bonacchi, G. Pagliai, A. Grossi, M. Parola, N. Navari, et al. Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells Am J Physiol Gastrointest Liver Physiol, January 1, 2006; 290(1): G120 - G128. [Abstract] [Full Text] [PDF]

				B Bressler, R Pinto, D El-Ashry, and E J Heathcote Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection? Gut, March 1, 2005; 54(3): 407 - 410. [Abstract] [Full Text] [PDF]

				T. G. DeLoughery Thrombocytopenia in Critical Care Patients J Intensive Care Med, November 1, 2002; 17(6): 267 - 282. [Abstract] [PDF]

				I. C. Haznedaroglu, H. Goker, M. Turgut, Y. Buyukasik, and M. Benekli Thrombopoietin as a Drug: Biologic Expectations, Clinical Realities, and Future Directions Clinical and Applied Thrombosis/Hemostasis, July 1, 2002; 8(3): 193 - 212. [Abstract] [PDF]

				E.-M. Wolber and W. Jelkmann Thrombopoietin: The Novel Hepatic Hormone Physiology, February 1, 2002; 17(1): 6 - 10. [Abstract] [Full Text] [PDF]

				J. Hambleton, L. L. Leung, and M. Levi Coagulation: Consultative Hemostasis Hematology, January 1, 2002; 2002(1): 335 - 352. [Abstract] [Full Text]

				A. Zaman, T. Becker, J. Lapidus, and K. Benner Risk Factors for the Presence of Varices in Cirrhotic Patients Without a History of Variceal Hemorrhage Arch Intern Med, November 26, 2001; 161(21): 2564 - 2570. [Abstract] [Full Text] [PDF]

				M. Peck-Radosavljevic, M. Wichlas, J. Zacherl, G. Stiegler, P. Stohlawetz, M. Fuchsjager, A. Kreil, S. Metz-Schimmerl, S. Panzer, R. Steininger, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production Blood, February 1, 2000; 95(3): 795 - 801. [Abstract] [Full Text] [PDF]

				B. Altun, M. Arici, I. C. Haznedaroglu, C. Usalan, Y. Erdem, U. Yasavul, C. Turgan, S. Caglar, and S. Kirazli Serum thrombopoietin levels in haemodialysis patients: involvement of arteriovenous fistula Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2173 - 2177. [Abstract] [Full Text] [PDF]

				J Goulis, T N Chau, S Jordan, A B Mehta, A Watkinson, K Rolles, and A K Burroughs Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation Gut, May 1, 1999; 44(5): 754 - 758. [Abstract] [Full Text] [PDF]

				S. Qian, F. Fu, W. Li, Q. Chen, and F. J. de Sauvage Primary Role of the Liver in Thrombopoietin Production Shown by Tissue-Specific Knockout Blood, September 15, 1998; 92(6): 2189 - 2191. [Full Text] [PDF]